
Last year, Americans spent less on medicines per capita (3.5%) because of a greater availability of lower costing generics, a decline in the use of brand-name products, lower levels of price increases, and a reduction in spending on new medicines, according to a new report from the IMS Institute for Healthcare Informatics.